ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/21/2025
Back to search
Official data from USPTO
COHERUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
COHERUS
ST13
US500000090858291Class
5, 42, 44
Filing
90858291
Registration
6921362
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
08/22/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
07/30/2021
Registration date
12/13/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/13/2022
Last transaction
08/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/13/2019
First use in commerce
01/13/2019
Drawing code
4
Owner type
03
Owner location
REDWOOD CITY, CA
Examiner
FATHY, DOMINIC
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
COHERUS ONCOLOGY, INC.
COHERUS BIOSCIENCES, INC.
Representatives
Perry J. Viscounty LATHAM & WATKINS LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceuticals for human immune diseases and conditions; pharmaceuticals for use in stimulating white blood cell production; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of inflammation; Pharmaceuticals for the treatment of cancerautoimmune diseasesmetabolic diseasesophthalmic diseases and conditions; Pharmaceutical preparations for the prevention and treatment of auto-immuneinflammatoryhematologicalhepatologicalcardiovascularpulmonarycentral nervous systemneurological systempaininflammationdermatologicgastro-intestinalhormonalpsychiatricinfectious-relatedviralmetaboliconcologicophthalmicrespiratorydigital ulcersmusculo-skeletalgenitourinarysexual dysfunctioncerebrovascular diseases and disorders; vaccines; anxiolytics; anti-allergics; anti-infectives; pharmaceutical preparations for treatment of ocular diseases and disorders; pharmaceuticals for the treatment of oncologyimmunologyophthalmology diseases and disorders
Class 42
researchdevelopment and consulting services in the pharmaceutical research and biotechnology fields; consultingresearch and development in the medical field
Class 44
providing information in the fields of health and medicine; consulting services in the field of pharmaceuticals and medical care
Publications
History of USPTO decisions and trademark events.
17 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/16/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/13/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/13/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/27/2022
PUBO
PUBLISHED FOR OPPOSITION
09/27/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/24/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/23/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/22/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/22/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/22/2022
GNRT
NON-FINAL ACTION E-MAILED
02/22/2022
CNRT
NON-FINAL ACTION WRITTEN
02/22/2022
DOCK
ASSIGNED TO EXAMINER
02/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/27/2021
NWAP
NEW APPLICATION ENTERED
08/03/2021
Continuous trademark protection
Get notified about every new filing that threatens COHERUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.